L & S Advisors Inc Has $1.43 Million Position in BrightSpring Health Services, Inc. (NASDAQ:BTSG)

L & S Advisors Inc lessened its stake in shares of BrightSpring Health Services, Inc. (NASDAQ:BTSG) by 1.4% in the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 83,752 shares of the company’s stock after selling 1,193 shares during the quarter. L & S Advisors Inc’s holdings in BrightSpring Health Services were worth $1,426,000 as of its most recent SEC filing.

A number of other hedge funds also recently modified their holdings of the stock. FMR LLC lifted its position in BrightSpring Health Services by 17.2% during the third quarter. FMR LLC now owns 18,169,187 shares of the company’s stock worth $266,724,000 after acquiring an additional 2,664,582 shares during the last quarter. Norges Bank bought a new position in shares of BrightSpring Health Services during the fourth quarter worth approximately $26,065,000. Raymond James Financial Inc. acquired a new stake in BrightSpring Health Services during the 4th quarter worth approximately $18,257,000. Vanguard Group Inc. boosted its stake in BrightSpring Health Services by 5.3% in the 4th quarter. Vanguard Group Inc. now owns 5,325,093 shares of the company’s stock valued at $90,686,000 after purchasing an additional 268,132 shares during the period. Finally, Walleye Capital LLC grew its holdings in BrightSpring Health Services by 388.0% in the 3rd quarter. Walleye Capital LLC now owns 167,112 shares of the company’s stock valued at $2,453,000 after buying an additional 132,869 shares in the last quarter.

BrightSpring Health Services Stock Down 2.1 %

Shares of NASDAQ:BTSG opened at $18.03 on Friday. The firm has a market cap of $3.15 billion, a P/E ratio of -69.35 and a beta of 2.20. BrightSpring Health Services, Inc. has a 12-month low of $9.98 and a 12-month high of $24.82. The business has a fifty day simple moving average of $20.13 and a 200 day simple moving average of $18.06. The company has a quick ratio of 0.97, a current ratio of 1.35 and a debt-to-equity ratio of 1.63.

Analysts Set New Price Targets

A number of brokerages have recently issued reports on BTSG. Bank of America boosted their target price on shares of BrightSpring Health Services from $19.00 to $21.00 and gave the company a “buy” rating in a research report on Wednesday, December 11th. CJS Securities assumed coverage on BrightSpring Health Services in a report on Thursday, December 12th. They issued an “outperform” rating and a $27.00 target price on the stock. UBS Group boosted their target price on shares of BrightSpring Health Services from $22.00 to $30.00 and gave the stock a “buy” rating in a research note on Wednesday, January 29th. Finally, Morgan Stanley increased their price target on BrightSpring Health Services from $19.00 to $20.00 and gave the company an “overweight” rating in a research note on Tuesday, December 17th. One investment analyst has rated the stock with a hold rating and nine have given a buy rating to the stock. According to data from MarketBeat.com, BrightSpring Health Services currently has an average rating of “Moderate Buy” and a consensus target price of $21.67.

About BrightSpring Health Services

BrightSpring Health Services, Inc operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations.